Cera Sanitaryware Ltd Q3 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/turn7r8fmw19csyacle6xqqm.pdf

# 1. Financial Performance

## A. Key Figures
   *   **Revenue from Operations:** **₹499 Cr** Q3 FY'26 · **₹449 Cr** Q3 FY'25 (+1%)
   * EBITDA Margin: **10.2%** Q3 FY'26 · **13.2%** Q3 FY'25 (down YoY)
   *   **PAT:** **₹24 Cr** Q3 FY'26 · **₹46 Cr** Q3 FY'25 (-48%)
   * **EPS:** **₹18.35** Q3 FY'26 · **₹35.56** Q3 FY'25 (-48.4%)
   *   **Net Working Capital:** **79 days** Q3 FY'26 · **81 days** Q3 FY'25 (-2 days)

## B. Revenue Growth
   *   **Steady Recovery Underway:** Revenue growth resumed after years of stagnation, with **strong sequential momentum** in Q2 (5–6%) and a modest 1% YoY uptick in Q3, signaling early-stage demand recovery.
   *   **Base Comparison Dynamics:** Q3 growth appears muted due to a high prior-year base, despite underlying improvement in sequential trends.

## C. EBITDA Margin
   *   **Margin Pressure from Transitory Costs:** EBITDA margin held at 2% despite headwinds from **higher trade discounts**, **elevated brass costs**, and **increased publicity spend**, which suppressed profitability versus prior year.
   *   **Near-Term Recovery Expected:** Margins anticipated to rebound sharply to **13–14% in Q4**, driven by favorable phasing and cost normalization, indicating the current weakness is largely temporary.

## D. Profit After Tax
   *   **Earnings Hit by Exceptional Liabilities:** PAT decline primarily attributable to **one-time wage code-related charges totaling ₹46 Cr**, including gratuity and leave encashment, distorting YoY comparability.
   *   **Core Earnings Likely Resilient:** Excluding exceptional items, underlying profitability shows greater stability despite margin pressures.

## E. Cash Flow
   *   **Working Capital Efficiency Improved:** Y-o-Y reduction in inventory and receivables days drove a **2-day compression in net working capital**, reflecting tighter operational execution.

---

# 2. Product & Segment Performance

## A. Key Figures
   *   **Revenue Mix:** **48%** Sanitaryware · **40%** Faucetware · **10%** Tiles · **2%** Wellness
   * YoY Growth: Sanitaryware +6.4% · Faucetware +18.2% · Tiles +5.7% · Wellness +29.4%
   *   **Product Tier Mix:** **44%** premium · **35%** mid · **21%** entry-level
   *   **Geographic Sales Mix:** **41%** Tier 3 · **36%** Tier 1 · **23%** Tier 2 cities
   *   **Outsourcing Rate:** **61%** Sanitaryware · **47%** Faucetware (Q3)

## B. Sanitaryware Sales
   *   **Demand Tailwinds:** Growth supported by a healthy residential upcycle, rising premiumization, and meaningful recovery in rural demand.
   *   **Pricing Action:** Implemented **4% average price hike** on Sanitaryware amid stable volume trends and improving underlying demand.
   *   **Growth Resilience:** Recent quarterly growth of **5%–6%** driven by demand momentum and internal initiatives, with no price increases contributing to prior quarter growth.

## C. Faucetware Sales
   *   **Staggered Pricing Strategy:** Delayed **11% price hike** to March 1 to avoid double escalation, following a prior increase in September 2024.
   *   **Margin Protection:** Strong operational improvements post-September hike helped preserve margins despite input cost pressures.

## D. Product Mix
   *   **Strategic Segmentation:** Portfolio-led approach with distinct brand positioning enables targeted coverage across price bands and regional demand cycles.
   *   **Manufacturing Shift:** Increasing in-house production of complex products, while outsourcing simpler, lower-margin items to optimize efficiency.

---

# 3. Manufacturing & Capacity

## A. Key Figures
   *   **Capacity Utilization:** **102%** Faucetware · **82%** Sanitaryware
   *   **Faucetware Capacity:** Expanded to **4 lakh units**, scalable to **6 lakh units** with existing infrastructure

## B. Capacity Utilization
   *   **Overutilization in Faucetware:** Production running above nameplate capacity reflects strong demand and operational efficiency gains.
   *   **Efficiency-Led De Facto Expansion:** Output growth without greenfield investment achieved through process improvements, effectively creating a "new plant within the plant."

## C. Brownfield Expansion
   *   **Scalable Infrastructure:** Civil works completed to support up to 6 lakh units; incremental expansion to 6 lakh achievable in **3–4 months** with balancing equipment.

## D. New Facility Plans
   *   **Sanitaryware Greenfield Decision Pending:** Land secured, but construction start deferred to Q4 pending assessment of **demand sustainability** and market conditions.

---

# 4. Channel & Distribution

## A. Retail & Project Mix
   *   **Project Segment Pressure:** Management acknowledged continued muted demand in the project segment, necessitating higher discounts to sustain sales.

## B. Tier-wise Sales
   *   **Regional Leadership Shift:** Uttar Pradesh has overtaken South India as the top-performing zone, marking a strategic shift in regional demand dynamics.
   *   **Broadening Demand Recovery:** Previously weak markets like **Bihar and Jharkhand** are showing early signs of demand recovery, suggesting expansion of the retail consumption base.

## C. Dealer Network
   *   **Enhanced Channel Control:** Dealer management program is advancing, improving visibility into **secondary sales** and **channel inventory** for more precise operational execution.

---

# 5. Brand & Strategic Initiatives

## A. Key Figures
   * Publicity Expenditure (9M): ₹35.58 Cr (vs. ₹40.89 Cr prior year)
   * Senator & POLIPLUZ Sales (9M): ₹7–8 Cr (revised FY projection: ₹20 Cr from ₹40 Cr)
   * Senator & POLIPLUZ Spending (Q3): ₹6 Cr (salaries: ₹3.6 Cr; promo/travel: remainder)
   *   **Promotional Spend (Full Year Est.):** ₹8–9 Cr for Senator & POLIPLUZ
   * Publicity Spend (Q3): ₹17.27 Cr (+₹3.4 Cr YoY)

## B. Senator Rollout
   *   **Strategic Brand Build:** Senator is central to the brand architecture, with a differentiated retail format, dedicated channel strategy, and expanded product portfolio driving calibrated expansion.
   *   **Store Network Scaling:** 32 flagship stores now operational; focus has shifted from rapid rollout to improving per-store performance and solidifying operating fundamentals.
   *   **Investment Phase Confirmed:** No revenue booked to date for Senator, reflecting ongoing pre-launch or early commercialization stage despite limited initial sales.
   *   **Funding & Execution:** Growth funded by a strong balance sheet, with disciplined capital allocation supporting organizational build-out and infrastructure development.

## C. POLIPLUZ Build-up
   *   **Distribution Expansion:** POLIPLUZ reaches market via 65 distributors and 750 dealers, with emphasis on building execution capabilities in value-focused segments.
   *   **Build Phase Priorities:** Team formation complete; current focus on establishing operating frameworks and ground-level execution rather than aggressive scale.
   *   **Spending Drivers:** Higher Q3 publicity costs linked to phased launch activities for POLIPLUZ and Senator, within unchanged total annual budget.

## D. Loyalty Program & Operational Enhancements
   *   **Digital Transformation:** Retailer loyalty program (28,000+ enrolled) will shift to full automation via BMS integration, enabling auto-capture of purchases and seamless point accrual.
   *   **Margin Resilience:** New product launches and operational efficiencies implemented to counter external pressures and protect profitability.
   *   **Market Recovery Focus:** Targeted strategies in underperforming markets over the past 3–5 quarters, including product mix adjustments, are improving regional performance.

---

# 6. Input Cost & Margin Risks

## A. Key Figures
   *   **Brass Price:** **INR800/kg** (Q3 peak) · **INR640/kg** (9M avg) (+~12%)
   * Gas Cost: INR35.70/m³ Q3 FY'26 (+6.5% YoY) · 3.8% of revenue
   *   **Trade Discounts:** **12% YoY increase** in project spends driving margin pressure

## B. Brass Price Impact
   *   **Margin Pressure from Brass:** Sharp rise in brass costs significantly impacted COGS, contributing to a **~300 bps EBITDA and gross margin decline**, despite delayed price adjustments.
   *   **Calibrated Pricing Response:** Implemented targeted price hikes in Faucetware and Sanitaryware to offset input cost inflation while maintaining competitive positioning.
   *   **Neutral Market Share Impact:** Industry-wide price adjustments during inflationary periods limit share shifts, as both large and small players pass on costs equally.

## C. Gas Cost Pressure
   *   **Significant Utility Inflation:** Gas costs surged 32% YoY, with 69% sourced from GAIL and 31% from Sabarmati, now representing **8% of revenue**.
   *   **Price Increase Adequate to Date:** Recent pricing actions fully offset cost increases through current period; further adjustments remain contingent on input cost trajectory.

## D. Trade Discount Trend
   *   **Project-Led Margin Drag:** EBITDA margin contraction primarily driven by elevated trade discounts linked to **double-digit growth in project segment spending**, while retail discounts held flat.
   *   **Cost Discipline Emphasized:** Ongoing focus on supply chain efficiency and operational rigor to counter margin pressures from inputs and promotional spend.

---

# 7. Guidance & Outlook

## A. Key Figures
   *   **Revenue Guidance:** **7%–8%** full-year growth maintained
   *   **Senator & POLIPLUZ Revenue Forecast:** **₹100–120 Cr** (revised down from ₹150 Cr)
   *   **EBITDA Margin:** **10%** reported in current quarter · **13%–14%** expected in Q4 · **15%–16%** targeted for FY '27

## B. Revenue Forecast
   *   **Confident Growth Trajectory:** Management affirms structural and sustainable recovery, underpinned by urbanization, housing quality upgrades, and formalization driving branded bathroom solutions demand.
   *   **Positive Momentum Ahead:** Green shoots in retail and project segments support expectations of continued **double-digit growth momentum** into Q4 and next fiscal year.
   *   **Pricing Impact Timing:** Recent price hike implemented only in Q4, with no prior increases in Q3, implying margin and revenue benefits will flow from next quarter onward.

## C. Margin Recovery
   *   **Near-Term Pressure, Medium-Term Recovery:** Current margin weakness attributed to temporary cost phasing and one-off expenses from new ventures; **Q4 typically sees stronger fixed cost absorption** due to seasonality.
   *   **Path to Margin Normalization:** Margins expected to rebound to **13%–14% in Q4** and return to **15%–16% in FY '27**, supported by revenue scale-up and recent pricing action.
   *   **Resilient Foundation:** Strong balance sheet, diversified portfolio, and ongoing investments position the company to capture demand recovery with disciplined execution.

## D. Capex Plan
   *   **Prudent Capital Allocation:** FY '26 capex at **₹2 Cr** through December '25, focused on maintenance and targeted brand/retail initiatives, reflecting disciplined investment approach.
   *   **Strategic Budgeting Ahead:** Detailed financial planning for Senator and POLIPLUZ to be finalized post-Q4, incorporating market performance and feedback for next-year targets.